Diapharma/Multiplate® TRAPtest, 3x1ml/08116679001/Kit/3x1ml

Description:

Multiplate® TRAPtest is a reagent kit used for platelet aggregation research studies for the evaluation of normal platelet function on the Multiplate® Analyzer and for the research evaluation of qualitative platelet function inhibition. Sensitive to the action of glycoprotein (Gp) IIb/IIIa receptor antagoNISTs and/or a deficiency of GpIIb/IIIa receptors.

Please note the catalog # for Multiplate® TRAPtest Kit has changed to 08116679001. You may have previously ordered this product under catalog #s MP0250 or 0675883190.

Kit Composition:

Reagents, Storage and StABIlity

• 08116679001: Multiplate® TRAPtest reagent, Kit, 3 x 1.0 mL. 150 tests. Reagent is stable until the expiration date printed on the vial label when stored at 2-8°C. Stable 7 days after reconstitution when stored at 2-8°C. Stable 4 weeks after reconstitution when stored at < -20°C. Stable for 24 hours at room temperature after one time thawing.

Also available

• 06675727190: Multiplate® TRAPtest Aliquot Vials, Box, 100 color coded (yellow) micro test tubes.

No longer available

• MP0150: Multiplate® TRAPtest reagent, Bag, 1 x 1.0 mL, 5 color coded (yellow) micro test tubes for aliquotation. 50 tests.
• MP0195: Multiplate® TRAPtest reagent, Kit, 1 x 1.0 mL. 50 tests.

Measurement Principle:

In the TRAPtest, platelets are activated by TRAP-6, a peptide that mimics the activation of platelets by the action of thrombin. Thrombin is the most potent platelet activator. The action of thrombin is not blocked by the antiplatelet agents Aspirin® or clopidogrel. However, thrombin (and TRAP-6) activated platelets are blocked by the action of GPIIb/IIIa antagoNISTs (e.g., ReoPro®, Aggrastat® and Integrilin®).

Mission Statement

Diapharma Group, Inc. in West Chester, Ohio sells hemostasis, thrombosis, platelet function testing, instrumentation, and apoptosis products in the diagnostic and research fields and provides strong technical competence and experience to ensure customer expectations will be met or exceeded.

diapharma hemostasis chromogenic clotting elisa assay test kit

History

The Diapharma Group, Inc. formed on January 1, 1997 from Pharmacia Hepar, Inc. in Franklin, Ohio, and began as the exclusive US and Canadian distributor of the Chromogenix substrates and assays.

Over a quarter-century ago, Chromogenix developed the first chromogenic substrate technology under the former name, Kabi Diagnostica. Kabi later merged with Pharmacia. Some of Diapharma’s current staff worked inside the Chromogenix department within Pharmacia’s heparin manufacturing plant.

In 1998, Diapharma moved to West Chester, Ohio, where it remains today. Over the years, Diapharma expanded its product line to include a variety of hemostasis, cell death, platelet function, ecotoxicology, assays, reagents, antibodies and instruments from superior manufacturers.

In 2017, Diapharma celebrated twenty years of success